Business
Notice of Results & Change of Auditor
Notice of Results & Change of Auditor.
About this update from Renalytix Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 4033B\n Renalytix AI PLC\n 10 June 2021\n \n \n \n Renalytix AI plc\n \n (\"Renalytix\" or the \"Company\")\n \n \n \n \n \n Renalytix to Report Financial Results for Fiscal Third Quarter 2021 and Provide Corporate Update\n \n \n \n \n \n \n Announces Change of Auditor to Ernst & Young LLP\n \n \n \n \n \n \n \n NEW YORK, \n \n \n June 10, 2021 \n \n - Renalytix AI plc \n (LSE\n : RENX) (NASDAQ: RNLX) today \n announced the Company will release fiscal third quarter 2021 financial results on Tuesday, June 15, 2021, before market open. The Company will host a corresponding conference call and live webcast at 8:30 a.m. (EDT) / 1:30 p.m. (BST) to discuss the results and provide a corporate update.\n \n \n \n \n \n Conference Call Details:\n \n \n US/Canada Participant Toll-Free Dial-In Number: (833) 614-1551\n \n \n US/Canada Participant International Dial-In Number: (914) 987-7290\n \n \n United Kingdom International Dial-In Number: 0800 9174 860\n \n \n United Kingdom Local Dial-In Number: 0203 1070 289\n \n \n Conference ID:9287147\n \n \n \n \n \n \n Webcast Registration link: \n \n \n \n https://edge.media-server.com/mmc/p/saaze8yw\n \n \n \n \n \n \n \n Auditor Change\n \n \n The Audit Committee of the Company's Board of Directors approved the dismissal of Deloitte & Touche LLP effective May 12, 2021. Ernst & Young LLP has been appointed as the Company's successor auditor for U.S. reporting, effective May 12, 2021, and for the fiscal year ended June 30, 2021. PKF Littlejohn LLP remains the Company's U.K. statutory auditors.\n \n \n \n \n \n There were no disagreements with Deloitte on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedures. \n \n \n \n \n \n \n \n \n For further information, please contact:\n \n \n \n \n \n UK Investor Contact:\n \n \n \n \n \n Walbrook PR Limited\n \n \n \n \n \n Tel: 020 7933 8780 \n \n or \n \n \n [email protected]\n \n \n \n \n \n \n \n \n Paul McManus / Lianne Cawthorne\n \n \n \n \n Mob: 07980 541 893 / 07584 391 303\n \n \n \n \n \n \n \n \n \n \n \n \n \n US Investor Contact:\n \n \n \n \n \n Gilmartin Group\n \n \n \n \n \n \n i\n \n \n [email protected]\n \n \n \n \n \n \n \n \n Carrie M...